Sunday, January 6, 2013

Best Stocks To Invest In 3/27/2012-3

__
Allergan Inc. (NYSE:AGN) invites you to listen to David Pyott, Chairman of the Board, President and Chief Executive Officer, and Jeff Edwards, Executive Vice President, Finance and Business Development, Chief Financial Officer, discuss the Company’s fourth quarter and full year 2011 results on Thursday, February 2, 2012. The live Webcast can be accessed through the Allergan Web site, www.allergan.com, beginning at 8:00 a.m. Pacific Time. A replay of the discussion will be available shortly after the call and can be accessed through www.allergan.com, or by dialing 1-866-509-6767 for domestic locations or 1-203-369-1931 for international locations.

Allergan, Inc. operates as a multi-specialty healthcare company primarily in the United States, Europe, Latin America, and the Asia Pacific.

Cleantech Transit, Inc. (CLNO)
Cleantech Transit, Inc. is in the business of producing and conserving power. Cleantech Transit produces and sells clean electricity globally, with a focus on sustainable energies using renewable resources such as Geothermal, Solar and Wind. Cleantech Transit’s goal is to use innovative technologies to reduce electricity consumption and dependence on carbon based energy. Cleantech Transit, Inc. was founded in 2006 and is based in Scottsdale, Arizona.

Biomass is a renewable energy because it contains the energy which comes from the sun. Biomass is basically an organic material made from plants and animals. Through the process of photosynthesis, chlorophyll present in plants absorbs the energy from the sun by converting the carbon-dioxide present in air and water from the ground in carbohydrates. The chemical energy that is present in plants is passed onto the animals and people that eat them. So, when these plants and animals are burned they turn back into carbon dioxide and water and release the sun’s energy they contain. In this way, we can say that biomass is renewable source of energy because we can always produce more crops and plants and waste will always exist. As long as biomass is produced this source of renewable energy will last for ever. Examples of biomass include: plants, crops, trees and garbage.

Cleantech Transit, Inc. (CLNO) is pleased to announce it has met its funding requirement to secure the Company’s ability to earn in 25% of the 500KW Merced Project.

The Company is in the final stages of closing its initial interest in the Merced Project and is currently working on completing the necessary documentation and expects closing the transaction soon. As previously announced Cleantech has the option to earn up to 40% of the Merced Project and the Company plans to continue to work towards increasing its interest in the Merced Project as they move ahead.

For more information please visit official website of CLNO: www.cleantechtransit.com

Duke Energy Corporation (NYSE:DUK) has declared a quarterly cash dividend on its common stock of $0.25 per share. The dividend is payable on March 16, 2012 , to shareholders of record at the close of business Feb. 17, 2012 .

Duke Energy Corporation operates as an energy company in the Americas. It operates through three segments: U.S. Franchised Electric and Gas, Commercial Power, and International Energy.

Gilead Sciences Inc. (Nasdaq:GILD) announced that its corporate presentation will be webcast from the 30th Annual JPMorgan Healthcare Conference in San Francisco. John C. Martin, PhD, Gilead’s Chairman and Chief Executive Officer, will provide an overview of the company on Monday, January 9 at 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time). To access the live webcast or a replay via the internet, log on to www.gilead.com. Please connect to the company’s website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary to listen to the webcast. The replay will be available for 14 days following the presentation.

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

No comments:

Post a Comment